Synta Pharmaceuticals Corp. (SNTA)
-NasdaqGM 7.50 
0.01(0.13%) May 17, 4:00PM EDT|After Hours
:
7.50 0.00 (0.00%) May 17, 4:32PM EDT
| Prev Close: | 7.49 |
|---|
| Open: | 7.55 |
|---|
| Bid: | 7.30 x 300 |
|---|
| Ask: | 7.56 x 500 |
|---|
| 1y Target Est: | 15.90 |
|---|
| Beta: | 2.39 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 7.36 - 7.57 |
|---|
| 52wk Range: | 3.77 - 11.88 |
|---|
| Volume: | 548,537 |
|---|
| Avg Vol (3m): | 698,781 |
|---|
| Market Cap: | 517.73M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.10 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Synta Announces Presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual MeetingBusiness Wire(Wed, May 15)
- Synta Is a Run-Up Trade Into ASCO Lung Cancer Dataat TheStreet(Tue, May 14)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Fri, May 10)
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarinat TheStreet(Fri, May 10)
- Synta Pharmaceuticals Becomes Oversold (SNTA)at TheStreet(Wed, May 8)
- Why Synta Pharmaceuticals Shares Sankat Motley Fool(Tue, May 7)
- SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other EventsEDGAR Online(Mon, May 6)
- SYNTA PHARMACEUTICALS CORP FinancialsEDGAR Online Financials(Sat, May 4)
- Synta Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 30)
- Synta Pharmaceuticals Corp. Earnings Call scheduled for 10:00 am ET todayCCBN(Tue, Apr 30)
- Q1 2013 Synta Pharmaceuticals Corp. Earnings Release - Before Market OpenCCBN(Tue, Apr 30)
- Synta Provides Clinical Updates and Reports First Quarter 2013 Financial ResultsBusiness Wire(Tue, Apr 30)
- SYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Apr 29)
- Synta Pharmaceuticals Earnings Preview: Get Ahead of the Analystsat Wall St. Cheat Sheet(Mon, Apr 29)
- Biotech Stock Mailbag: ASCO, Sarepta, Cel-Sci and Hate Mail!at TheStreet(Fri, Apr 26)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.21 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.30 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
View More